Ann Neurol
- FADDA G, Yea C, O'Mahony J, Waters P, et al
Epstein-Barr Virus Strongly Associates With Pediatric Multiple Sclerosis, But Not
Myelin Oligodendrocyte Glycoprotein-Antibody-Associated Disease.
Ann Neurol. 2024 Feb 27. doi: 10.1002/ana.26890.
- SHU Y, Huang R, Li Q, Lu Y, et al
Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy Is Associated with
HLA-A*3303 and HLA-DPB1*0501.
Ann Neurol. 2024 Feb 24. doi: 10.1002/ana.26899.
Int J Clin Pract
- FARJOUD KOUHANJANI M, Hosseini SA, Mousavi SM, Noroozi Z, et al
Takotsubo Cardiomyopathy and Autoimmune Disorders: A Systematic Scoping Review of
Published Cases.
Int J Clin Pract. 2024;2024:7259200.
J Nephrol
- ARNAERT S, Schepens N, Deleu L, Malfait T, et al
Case report: renal recovery in Goodpasture's syndrome treated with rituximab.
J Nephrol. 2024 Mar 1. doi: 10.1007/s40620-024-01892.
- VAZ DE CASTRO PAS, Amaral AA, Almeida MG, Selvaskandan H, et al
Examining the association between serum galactose-deficient IgA1 and primary IgA
nephropathy: a systematic review and meta-analysis.
J Nephrol. 2024 Mar 1. doi: 10.1007/s40620-023-01874.
J Neuroimmunol
- KMEZIC I, Press R, Glenewinkel H, Doppler K, et al
Low-dose rituximab treatment in a patient with anti-neurofascin-155 IgG4
autoimmune nodopathy.
J Neuroimmunol. 2024;389:578326.
- SERAFINI B, Benincasa L, Rosicarelli B, Aloisi F, et al
EBV infected cells in the multiple sclerosis brain express PD-L1: How the virus
and its niche may escape immune surveillance.
J Neuroimmunol. 2024;389:578314.
- FRID K, Usmann A, Markovits-Pachter T, Binyamin O, et al
Granagard administration prolongs the survival of human mesenchymal stem cells
transplanted into a mouse model of multiple sclerosis.
J Neuroimmunol. 2024;389:578313.
J Neurol
- SCHERER L, Soudant M, Pittion-Vouyovitch S, Debouverie M, et al
Risk of secondary progression in patients with highly active multiple sclerosis
treated with natalizumab: a real-life study.
J Neurol. 2024 Feb 29. doi: 10.1007/s00415-024-12266.
- TOLJAN K, Briggs FBS
Male sexual and reproductive health in multiple sclerosis: a scoping review.
J Neurol. 2024 Feb 28. doi: 10.1007/s00415-024-12250.
- LEAVITT VM, Tozlu C, Nelson KE, Boehme AK, et al
A randomized controlled trial of oral antipyretic treatment to reduce overheating
during exercise in adults with multiple sclerosis.
J Neurol. 2024 Feb 28. doi: 10.1007/s00415-023-12147.
- VAN DAM M, Krijnen EA, Nauta IM, Fuchs TA, et al
Identifying and understanding cognitive profiles in multiple sclerosis: a role
for visuospatial memory functioning.
J Neurol. 2024 Feb 26. doi: 10.1007/s00415-024-12227.
- NGUYEN TT, Chae J, Kang JJ, Oh SY, et al
Saccadic fatigue as an early indicator for diagnosing myasthenia gravis.
J Neurol. 2024 Feb 25. doi: 10.1007/s00415-024-12262.
- WEISS MD, Freimer M, Leite MI, Maniaol A, et al
Improvement of fatigue in generalised myasthenia gravis with zilucoplan.
J Neurol. 2024 Feb 24. doi: 10.1007/s00415-024-12209.
Kidney Int
-
KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil
Cytoplasmic Antibody (ANCA)-Associated Vasculitis.
Kidney Int. 2024;105.
- FLOEGE J, Jayne DRW, Sanders JF, Tesar V, et al
Executive summary of the KDIGO 2024 Clinical Practice Guideline for the
Management of ANCA-Associated Vasculitis.
Kidney Int. 2024;105:447-449.
Lancet Neurol
- HEIDBREDER A
Sleep matters in anti-LGI1 encephalitis.
Lancet Neurol. 2024;23:221-223.
Mult Scler
- KRIEGER SC, Sinks S, Huang F, Steverson J, et al
The impact of social distancing measures on anti-JC virus serostatus changes
before and during the COVID-19 pandemic in US patients with multiple sclerosis.
Mult Scler. 2024 Feb 26:13524585241232274. doi: 10.1177/13524585241232274.
- MILLER AE
Dissemination in time as a requirement for diagnosis of multiple sclerosis: Time
for a change?
Mult Scler. 2024 Feb 27:13524585241233999. doi: 10.1177/13524585241233999.
- NAKKEN O, Aarseth JH, Wergeland S, Stigum H, et al
BCG vaccination and multiple sclerosis risk: A Norwegian cohort study.
Mult Scler. 2024 Feb 27:13524585241230440. doi: 10.1177/13524585241230440.
- LIM TRU, Kumaran SP, Suthiphosuwan S, Espiritu AI, et al
Limited utility of adding 3T cervical spinal cord MRI to monitor disease activity
in multiple sclerosis.
Mult Scler. 2024 Feb 28:13524585241228426. doi: 10.1177/13524585241228426.
- HEESEN C, Luhmann D
Reply: Mobile health interventions in multiple sclerosis: A systematic review.
Mult Scler. 2024 Feb 29:13524585241234777. doi: 10.1177/13524585241234777.
- KARI S, Bucciarelli F, Angles T, Oster AC, et al
Increased levels of circulating soluble CD226 in multiple sclerosis.
Mult Scler. 2024 Feb 29:13524585241234489. doi: 10.1177/13524585241234489.
- AFZAL RM, Romme Christensen J, Gynthersen RMM, Lebech AM, et al
Neoehrlichiosis associated with ocrelizumab in a patient with multiple sclerosis:
A case report.
Mult Scler. 2024 Feb 29:13524585241235542. doi: 10.1177/13524585241235542.
- GIULIANI G, Zilli C, Caramia F, Di Piero V, et al
SUNCT syndrome secondary to multiple sclerosis: Not only trigeminal neuralgia.
Mult Scler. 2024 Mar 1:13524585241235535. doi: 10.1177/13524585241235535.
Neurology
- AOTSUKA Y, Misawa S, Suichi T, Shibuya K, et al
Prevalence, Clinical Profiles, and Prognosis of CIDP in Japanese Nationwide
Survey: Analyses of 1,257 Diagnosis-Confirmed Patients.
Neurology. 2024;102:e209130.
- MARRIE RA, Salter A
Off-Road Testing: Outcome Reporting Bias in Multiple Sclerosis Trials.
Neurology. 2024;102:e208099.
- LEMMENS CMC, van Amerongen S, Strijbis EM, Killestein J, et al
Outcome Reporting Bias in Clinical Trials Researching Disease-Modifying Therapy
in Patients With Multiple Sclerosis.
Neurology. 2024;102:e208032.
- BOURDETTE D, Wooliscroft L
The Challenges of Treating Late-Onset Multiple Sclerosis.
Neurology. 2024;102:e209146.
- MOURESAN EF, Mentesidou E, Berglund A, Mckay KA, et al
Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis:
A Swedish Nationwide Study.
Neurology. 2024;102:e208051.
-
Characteristics, Prevalence, and Clinical Relevance of Juxtacortical Paramagnetic
Rims in Patients With Multiple Sclerosis.
Neurology. 2024;102:e209252.
PLoS One
- LIU X, Xue J, Li T, Wu Q, et al
Quantitative detection and prognostic value of antibodies against M-type
phospholipase A2 receptor and its cysteine-rich ricin domain and C-type lectin
domains 1 and 6-7-8 in patients with idiopathic membranous nephropathy.
PLoS One. 2024;19:e0298269.
Semin Hematol
- KISHTAGARI A, Corty RW, Visconte V
Clonal hematopoiesis and autoimmunity.
Semin Hematol. 2024 Feb 2:S0037-1963(24)00011.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016